VULKETAN DIN 02242467
Status: Cancelled Post Market
Holder: ELANCO CANADA LIMITED
Molecule: KETANSERIN (KETANSERIN TARTRATE)
Health Canada record
| Active ingredient(s) | KETANSERIN (KETANSERIN TARTRATE) 2.5 MG |
|---|---|
| Dosage form | Gel |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 07-Mar-2003 |
| Current status date | 25-Apr-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20619 | 2018-03-14 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 13649 | 2012-09-14 | New Drug Submission (NDS) | Change in ownership |
| 12421 | 2011-06-09 | Supplement to a New Drug Submission (SNDS) | Changes in manufacturing |
| 12140 | 2011-03-11 | New Drug Submission (NDS) | Change in ownership |
| 3638 | 2004-05-19 | New Drug Submission (NDS) | |
| 6526 | 2000-08-02 | New Drug Submission (NDS) |